Holistic Financial Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,544
Closed -$215K 93
2022
Q2
$215K Hold
2,544
0.2% 83
2022
Q1
$223K Buy
+2,544
New +$220K 0.14% 96
2019
Q3
Sell
-4,067
Closed -$371K 96
2019
Q2
$371K Sell
4,067
-416
-9% -$35.2K 0.37% 35
2019
Q1
$386K Buy
4,483
+523
+13% +$42K 0.16% 64
2018
Q4
$304K Buy
3,960
+57
+1% +$4.44K 0.32% 39
2018
Q3
$301K Buy
+3,903
New +$289K 0.28% 45
2018
Q2
Sell
-1,625
Closed -$118K 258
2018
Q1
$118K Buy
1,625
+76
+5% +$5.79K 0.1% 98
2017
Q4
$117K Buy
+1,549
New +$117K 0.1% 100

Other funds holding NVS

Holistic Financial Partners's NVS Position: Q3 2022 in Review

Holistic Financial Partners sold out of Novartis (NVS) in Q3 2022, closing a stake of 2,544 shares — an estimated $215K sold.

Holistic Financial Partners first reported a position in NVS in Q4 2017 and held it in 8 quarters. The position peaked at $386K in Q1 2019. 1,088 funds tracked by Wall St. Rank hold NVS as of Q3 2022.

  • Holistic Financial Partners reported no remaining Novartis position as of Q3 2022 after selling out during the quarter.
  • Holistic Financial Partners sold 2,544 Novartis shares in Q3 2022, an estimated $215K.
  • Holistic Financial Partners first reported a position in Novartis in Q4 2017 and held it in 8 quarters.
  • Holistic Financial Partners's Novartis position peaked at $386K in Q1 2019.
  • 1,088 funds tracked by Wall St. Rank held Novartis as of Q3 2022.

Based on Holistic Financial Partners's 13F filing for Q3 2022, filed 9 Nov 2022.